Latest news with #ApolloHospitalsEnterprise
&w=3840&q=100)
Business Standard
17 hours ago
- Business
- Business Standard
Fancy dividends? Keep an eye on these 11 stocks today; check full list here
D-Street investors looking to pocket some passive income through dividends should keep an eye on the shares of Apollo Hospitals Enterprise, Industrial & Prudential Investment Company, Natco Pharma, Power Grid Corporation of India, and 7 other companies today, as they are set to trade ex-dividend tomorrow, August 19, 2025, according to BSE data. Other companies featured in the list include Elixir Capital, Jammu & Kashmir Bank, Refex Industries, R K Swamy, Shyam Metalics and Energy, Silver Touch Technologies, and Sumedha Fiscal Services. Notably, the ex-date refers to the day when a stock begins trading without the entitlement to dividend payouts. Therefore, investors who wish to receive the dividend must own the stock before the ex-date. The companies, however, finalize the list of eligible shareholders for the dividend payout on the record date. Among the listed companies, Industrial & Prudential Investment Company has announced the highest dividend reward for its shareholders. The company has declared a final dividend of ₹110 per share. Additionally, Industrial & Prudential Investment Company has set the record date on August 19, 2025, to determine shareholder eligibility for the dividend. Among others, Apollo Hospitals Enterprise has announced a final dividend of ₹10 per share for its shareholders, Natco Pharma has announced an interim dividend of ₹2 per share, Power Grid Corporation of India has declared a final dividend of ₹1.25 per share, and Indian Oil Corporation has announced a dividend. They have all set their record date on August 19 for determining shareholders' eligibility for the said announcements. Here is the complete list of stocks that will remain in focus today as they trade ex-dividend on August 19, along with their key details: Company Ex-date Announcement Record date Apollo Hospitals Enterprise Aug 19, 2025 Final Dividend - ₹10 Aug 19, 2025 Elixir Capital Aug 19, 2025 Final Dividend - ₹1.25 Aug 19, 2025 Industrial & Prudential Investment Company Aug 19, 2025 Final Dividend - ₹110 Aug 19, 2025 Jammu & Kashmir Bank Aug 19, 2025 Dividend - ₹2.1500 Aug 19, 2025 Natco Pharma Aug 19, 2025 Interim Dividend - ₹2 Aug 19, 2025 Power Grid Corporation of India Aug 19, 2025 Final Dividend - ₹1.2500 Aug 19, 2025 Refex Industries Aug 19, 2025 Interim Dividend - ₹0.50 Aug 19, 2025 R K Swamy Aug 19, 2025 Final Dividend - ₹1.50 Aug 19, 2025 Shyam Metalics and Energy Aug 19, 2025 Final Dividend - ₹2.25 Aug 19, 2025 Silver Touch Technologies Aug 19, 2025 Final Dividend - ₹0.50 Aug 19, 2025 Sumedha Fiscal Services Aug 19, 2025 Final Dividend - ₹1 Aug 19, 2025 (Source: BSE)
Business Standard
5 days ago
- Business
- Business Standard
Nifty trades above 24,600 level; European mkt advance
The domestic equity benchmarks traded with significant gains in afternoon trade, tracking positive global cues. Upbeat domestic CPI data further boosted market sentiment. Investors are closely watching the ongoing earnings season, FII activity, and key macroeconomic data releases expected later this week. Pharma, auto and metal shares advanced, while PSU bank and FMCG shares corrected. At 13:30 IST, the barometer index, the S&P BSE Sensex advanced 273.02 points or 0.34% to 80,508.61. The Nifty 50 index gained 126.54 points or 0.52% to 24,613.85. In the broader market, the S&P BSE Mid-Cap index rose 0.59% and the S&P BSE Small-Cap index added 0.51%. The market breadth was positive. On the BSE 2,159 shares rose and 1,790 shares fell. A total of 196 shares were unchanged. Economy: Indias retail inflation, measured by the Consumer Price Index (CPI), eased to 1.55% in July, down 55 basis points from 2.10% in June, according to data from the Ministry of Statistics & Programme Implementation. This marks the lowest year-on-year inflation rate since June 2017. Gainers & Losers: Apollo Hospitals Enterprise (up 6.92%), Hindalco Industrie (up 5.15%), Cipla (up 2.84%), Hero MotoCorp (up 2.76%) and Dr. Reddy's Laboratories (up 2.61%) were the major Nifty50 gainers. IndusInd Bank (down 1.07%), Adani Ports and Special Economic Zone (down 0.68%), Adani Enterprises (down 0.35%), Titan Company (down 0.30%) and ITC (down 0.24%) were the major Nifty50 losers. Apollo Hospitals Enterprise jumped 6.92% after the company reported 41.80% surge in consolidated net profit to Rs 432.80 crore on 14.87% increase in revenue from operations to Rs 5,842.10 crore in Q1 FY26 over Q1 FY25. Hindalco Industries rallied 5.51% after the company reporting a strong set of June quarter numbers, aided by a stellar India Aluminium performance and resilient results from its US subsidiary Novelis. Consolidated net profit rose 30% year-on-year to Rs 4,004 crore in Q1 FY26 from Rs 3,074 crore in Q1 FY25. Revenue from operations grew 13% to Rs 64,232 crore from Rs 57,013 crore a year earlier. Stocks in Spotlight: NIBE slipped 4.66% after the companys consolidated net profit dropped 75.97% to Rs 1.90 crore in Q1 FY26, compared to Rs 7.91 crore posted in Q1 FY25. Revenue from operations fell 25.04% to Rs 82.50 crore in Q1 FY26, down from Rs 110.06 crore in the same quarter last year. NMDC Steel surged 15.90% after the company reported consolidated net profit of Rs 25.56 crore in Q1 FY26, compared with a net loss of Rs 547.25 crore in Q1 FY25. Revenue from operations jumped 66.36% YoY to Rs 3,365.22 crore in Q1 June 2025. Cochin Shipyard rose 0.41%. The company reported a 7.8% rise in consolidated net profit to Rs 187.83 crore on a 38.5% increase in revenue from operations to Rs 1,068.59 crore in Q1 FY26 over Q1 FY25. FSN E-Commerce Ventures jumped 5.78% after the company reported 79% rise in net profit to Rs 24 crore on a 23% increase in revenue from operations to Rs 2,155 crore in Q1 FY26 as compared with Q1 FY25. Global Markets: European and Asian markets advanced on Wednesday after the latest U.S. inflation data raised hopes that the Federal Reserve could cut interest rates next month. In Japan, a report showed manufacturers grew more confident about business conditions after a trade agreement with the United States. The monthly poll, which tracks the Bank of Japan's quarterly tankan business survey, reportedly showed the manufacturers' sentiment index rising to plus 9 in August from plus 7 in July, marking a second straight month of improvement. Further, Japan's annual wholesale inflation slowed for the fourth straight month in July, data showed on Wednesday, underscoring the central bank's view that upward price pressure from raw material costs will dissipate. The corporate goods price index (CGPI), which measures the price companies charge each other for their goods and services, rose 2.6% in July from a year earlier, data showed, slowing from the previous month's 2.9% increase. It compared with the widely reported median market forecast for a 2.5% rise. On Wall Street, stocks ended higher on Tuesday as inflation data was tamer than expected, soothing investor fears that tariffs are not spiking prices. The trading session saw the S&P 500 and tech-heavy Nasdaq Composite close at fresh record highs. The S&P 500 added 1.1% to settle at 6,445.76, while the Nasdaq ended 1.4% higher at 21,681.90. The Dow Jones Industrial Average added about 483 points, or 1.1%, to close at 44,458.61. A widely followed measure of inflation accelerated slightly less than expected in July on an annual basis. The consumer price index increased a seasonally adjusted 0.2% for the month and 2.7% on a 12-month basis, the Bureau of Labor Statistics reported Tuesday. Excluding food and energy, the core CPI increased 0.3% for the month and 3.1% from a year ago. The monthly core rate was the biggest increase since January while the annual rate was the highest since February. Thursdays producer price index report on wholesale inflation will add another piece of the economic picture. The report comes ahead of the Feds Jackson Hole meeting on Aug. 21-23, which could also help shape expectations for the central banks next policy move.
Business Standard
5 days ago
- Business
- Business Standard
Apollo Hospitals gains after Q1 PAT jumps 42% YoY to Rs 433 cr
Apollo Hospitals Enterprise jumped 5.41% to Rs 7,628 after the company reported 41.80% surge in consolidated net profit to Rs 432.80 crore on 14.87% increase in revenue from operations to Rs 5,842.10 crore in Q1 FY26 over Q1 FY25. Profit before tax (PBT) increased 35.51% YoY to Rs 582.70 crore in the quarter ended 30 June 2025. EBITDA grew by 26.22% to Rs 852 crore in Q1 FY26, up from Rs 675 crore in Q1 FY25. This includes Apollo 24/7 costs of Rs 121 crore during the quarter (including Rs 24 crore in non-cash ESOP charges), compared to Rs 150 crore in Q1 FY25. On segmenetal front, revenue from healthcare services rose 11% YoY to Rs 2,935 crore. Revenue from Apollo Health and Lifestyle (AHLL) stood at Rs 435 crore, up 19% YoY, while revenue from Apollo HealthCo reached Rs 2,472 crore, also up 19% YoY. As of 30 June 2025, Apollo Hospitals had 8,030 operating beds across its network (excluding AHLL and managed beds). Overall hospital occupancy was at 65%, compared to 68% in the same period last year. Dr. Prathap C Reddy, chairman, Apollo Hospitals Enterprise, said: I am proud to see the resilient comeback in the first quarter of FY26, building on the strong foundation of Q4 FY25. I am glad to inform you that Q1 FY26 has delivered another robust set of results, with revenue growth in the double digits at 15% YoY and continued improvement in margins. Our performance demonstrates the power and resilience of our integrated model of healthcare delivery with all three engines - our core divisions, Healthcare Services, Retail Healthcare & Diagnostics, and Digital & Pharma Distribution, contributing to our performance. Patient numbers across our network increased year-on-year, reflecting both the deeper penetration of our Centers of Excellence and the growing confidence of communities in our integrated care model. The quarter saw us announce our ambitious growth strategy to add over 4,300 beds in the next five years with an investment of over 7,600 crore. The first phase of 2,000 beds is already in progress. We have added an existing 200-bed hospital in Bengaluru and will also be establishing a 500-bed greenfield hospital in the suburbs of the city to bring the total bed strength in Bengaluru to 1,500 beds. In Hyderabad, we are adding 160 beds at our existing Jubilee Hills and Secunderabad facilities, and with the upcoming facility in Gachibowli, our bed strength in the city will increase to 1,400 beds. On the digital front, Apollo 24/7 achieved a quarterly GMVof over Rs 682 crore, sustaining the platform's momentum and signaling the continuing strong demand for teleconsultetions, lab and pharmacy deliveries. This performance builds on the platform's FY25 GMV of Rs. 3,007 crore, demonstrating our success in creating a seamless care continuum from home to hospital. The demerger of our digital health and pharmacy business, approved in the last quarter, is now in the implementation phase. This strategic move will enable focused capital allocation and sharper growth plans with dedicated management teams for both hospital operations and omnichannel healthcare ecosystem, a structure designed to maximize synergies while preserving the Apollo ethos of quality and trust. Preventive healthcare remains at the heart of our mission. Through the Al-based Apollo ProHealth platform, we have crossed 25Million health assessments this quarter alone, guiding individuals on personalized wellness journeys and strengthening early -detection pathways. Patient access continues to guide our investments. We expanded our 'Care-Within-Reach' financing programs to additional tier2 and tier3 markets, ensuring that advanced treatments remain accessible to a broad segment of the population. Our efforts on sustainability saw us launch 'Green Health' initiatives in Mumbai and Hyderabad, achieving a 20% reduction in energy consumption per patient day and using ecofriendly materials across new construction projects. Looking ahead, we anticipate continued double digit revenue growth for FY26, underpinned by new hospital openings in Patna and Jaipur slated for QJ, further digital innovation, and deepening partnerships with state governments to bolster community-based health initiatives. I remain confident that Apollo will set new benchmarks in clinical excellence, patient experience, and sustainable growth-true to our founding mission of enabling healthier, happier lives for all." Meanwhile, the board of directors of the company has approved an investment of an amount not exceeding a sum of Rs 85 million for acquiring 85,00,000 equity shares of Rs 10 each of Apollo Gleneagles PET-CT Private (AGPCL) from its existing shareholder, Parkway Healthcare (Mauritius) PTE, representing 50% of the total paid-up equity share of AGPCL. Apollo Hospitals Enterprise has established a strong presence across the healthcare ecosystem, encompassing hospitals, pharmacies, primary care and diagnostic clinics, as well as various retail health models. The Group also offers telemedicine services in multiple countries, health insurance solutions, global project consultancy, and operates medical colleges, a nursing and hospital management college, and Medvarsity for e-learning. Additionally, it is supported by a dedicated research foundation.
Economic Times
6 days ago
- Business
- Economic Times
Apollo Hospitals Enterprise shares surge over 6% after Q1 net profit rises 42%
Apollo Hospitals Enterprise shares surged 6.3% to 7,695 on Wednesday following the company's robust performance in the first quarter (Q1) of FY26. ADVERTISEMENT The healthcare giant reported a consolidated net profit of Rs 433 crore for Q1FY26, marking a significant 42% increase compared to Rs 305 crore in the same period last year. Sequentially, profit after tax (PAT) rose 11% from Rs 390 crore recorded in Q4FY25. Revenue from operations grew 15% year-on-year to Rs 5,842 crore in Q1FY26, up from Rs 5,086 crore in Q1FY25. On a sequential basis, the topline improved 4.5% compared to Rs 5,592 crore in Q4FY25. Healthcare services revenue came in at Rs 2,974 crore in Q1FY26, rising from Rs 2,843 crore in the previous quarter (Q4FY25) and Rs 2,654 crore in the same quarter last year (Q1FY25).Retail health & diagnostics revenue reached Rs 435 crore in Q1FY26, up from Rs 394 crore in Q4FY25 and Rs 366 crore in Q1FY25. ADVERTISEMENT Digital health & pharmacy distribution revenue stood at Rs 2,472 crore in Q1FY26, compared to Rs 2,376 crore in the previous quarter and Rs 2,082 crore in the year-ago period. Unlock 500+ Stock Recos on App The positive earnings and steady revenue growth across all business segments have boosted investor confidence, driving the stock price upward. ADVERTISEMENT The 14-day Relative Strength Index (RSI) for Apollo Hospitals Enterprise is currently at 47.5. Typically, an RSI below 30 indicates that a stock is oversold and may be undervalued, while an RSI above 70 suggests it is overbought and could be due for a correction. At 47.5, the stock is in a neutral zone, showing neither strong buying nor selling a moving averages perspective, Apollo Hospitals Enterprise is exhibiting a bullish trend as it is trading above all 8 key Simple Moving Averages (SMAs) — ranging from the short-term 5-day SMA to the long-term 200-day SMA. This consistent position above multiple SMAs suggests strong upward momentum and positive investor sentiment. ADVERTISEMENT (You can now subscribe to our ETMarkets WhatsApp channel)
Time of India
6 days ago
- Business
- Time of India
Apollo Hospitals Enterprise shares surge over 6% after Q1 net profit rises 42%
Apollo Hospitals Enterprise shares surged 6.3% to 7,695 on Wednesday following the company's robust performance in the first quarter (Q1) of FY26. The healthcare giant reported a consolidated net profit of Rs 433 crore for Q1FY26, marking a significant 42% increase compared to Rs 305 crore in the same period last year. Sequentially, profit after tax (PAT) rose 11% from Rs 390 crore recorded in Q4FY25. Revenue from operations grew 15% year-on-year to Rs 5,842 crore in Q1FY26, up from Rs 5,086 crore in Q1FY25. On a sequential basis, the topline improved 4.5% compared to Rs 5,592 crore in Q4FY25. Segment-wise revenue performance: Healthcare services revenue came in at Rs 2,974 crore in Q1FY26, rising from Rs 2,843 crore in the previous quarter (Q4FY25) and Rs 2,654 crore in the same quarter last year (Q1FY25). Retail health & diagnostics revenue reached Rs 435 crore in Q1FY26, up from Rs 394 crore in Q4FY25 and Rs 366 crore in Q1FY25. Digital health & pharmacy distribution revenue stood at Rs 2,472 crore in Q1FY26, compared to Rs 2,376 crore in the previous quarter and Rs 2,082 crore in the year-ago period. The positive earnings and steady revenue growth across all business segments have boosted investor confidence , driving the stock price upward. Technical Outlook The 14-day Relative Strength Index (RSI) for Apollo Hospitals Enterprise is currently at 47.5. Typically, an RSI below 30 indicates that a stock is oversold and may be undervalued, while an RSI above 70 suggests it is overbought and could be due for a correction. At 47.5, the stock is in a neutral zone, showing neither strong buying nor selling pressure. From a moving averages perspective, Apollo Hospitals Enterprise is exhibiting a bullish trend as it is trading above all 8 key Simple Moving Averages (SMAs) — ranging from the short-term 5-day SMA to the long-term 200-day SMA. This consistent position above multiple SMAs suggests strong upward momentum and positive investor sentiment.
